A Stock With Stellar Fundamentals? CVS Health Corp (NYSE:CVS): Is It Right For You?

Stocks of CVS Health Corp (NYSE:CVS) traded higher last session on Wall Street, up 1.66% to $66.33.

CVS stock price is now 18.91% away from the 50-day moving average and 15.32% away from the 200-day moving average. The market capitalization of the company currently stands at $83.63B.

Top 5 Artificial Intelligence Stocks to Buy for 2024

By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it. According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."

Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"

Sponsored

With the price target enhanced from $55 to $75, Leerink Partners Upgraded its rating from Market Perform to Outperform for CVS Health Corp (NYSE: CVS). , while ‘Edward Jones’ rates the stock as ‘Buy’

In other news, Clark James David, SVP, Cont & Chief Acct Officer sold 7,513 shares of the company’s stock on Mar 05 ’25. The stock was sold for $498,488 at an average price of $66.35. Upon completion of the transaction, the SVP, Cont & Chief Acct Officer now directly owns 8,394 shares in the company, valued at $0.56 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Mar 05 ’25, Officer Clark James David bought 7,513 shares of the business’s stock. A total of $498,489 was incurred on buying the stock at an average price of $66.35. A total of 0.13% of the company’s stock is owned by insiders.

During the past 12 months, CVS Health Corp has had a low of $43.56 and a high of $80.75. As of last week, the company has a debt-to-equity ratio of 1.10, a current ratio of 0.81, and a quick ratio of 0.60.

The net profit margin was 1.24% and return on equity was 6.07% for CVS. The company reported revenue of $97.71 billion for the quarter, compared to $93.81 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 4.15 percent.

Related Posts